RDG fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Read-Gene SA engages in the medical research and testing. It develops cancer prevention treatment based on genetic tests. The company was founded on September 27, 2005 and is headquartered in Dobra, Poland.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
RDG does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company